OMCL
OMNICELL, INC.
NASDAQ · Healthcare · Medical - Healthcare Information Services · US
$38.97
+9.88%Year over year
Reported trailing growth
- Revenue
- +5.6%
- EBITDA
- +21.7%
- EBIT
- +254.6%
- EPS
- +126.7%
- Free cash flow
- +29.7%
- Operating cash flow
- +22.3%
Forward estimates
Based on analyst estimates
- Revenue
- -1.6%
- EBITDA
- +22.3%
- EPS
- +96.6%
Three-year CAGR
- Revenue
- -2.9%
- EBITDA
- +1.7%
- EBIT
- +3361.4%
- Net income
- -28.6%
- EPS
- -30.0%
- Free cash flow
- +72.1%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Sep 1, 2026